Gene therapy startup Immusoft raises $3M, appoints new CEO as it approaches clinical trials – GeekWire
GeekWire |
Gene therapy startup Immusoft raises $3M, appoints new CEO as it approaches clinical trials
GeekWire Sean Ainsworth joins Immusoft as its new CEO. (Immusoft Photo). Immusoft is looking to get its gene therapy technology into clinical trials, and the Seattle startup announced Friday that it has raised $3 million to kickstart that process. The funding … Immusoft Closes First Part of Series B Financing, New CEO to Lead … |
